NewsBenzingaSilo Pharma获得美国专利局通知,覆盖SPC-15的申请,该申请涉及其针对创伤后应激障碍的新型鼻内治疗药物的专利。 Silo Pharma获得美国专利局通知,覆盖SPC-15的申请,该申请涉及其针对创伤后应激障碍的新型鼻内治疗药物的专利。 Benzinga 2026.09.18 12:52 (GMT+0) Open on Benzinga Other news 2026 Financial Street Forum Annual Conference opens this afternoon; heads of four departments including Pan Gongsheng and Wu Qing to deliver keynote speeches Bithumb to suspend BLAST withdrawals on Oct 19 to support network migration to Ethereum Apple plans to release new products on four consecutive Fridays Gate Launches CLAUDIA Contracts, Trading Bots and Copy Trading Key News from Last Night and This Morning (October 18–19) Palantir Stock: AI In Production While Everyone Else Is Still Piloting (NASDAQ:PLTR)
2026 Financial Street Forum Annual Conference opens this afternoon; heads of four departments including Pan Gongsheng and Wu Qing to deliver keynote speeches